Flame Biosciences

Recent Finacing

Equity

Recent Raise

$100M

Flame Biosciences is a NYC-based clinical-stage biopharmaceutical company developing IL‑1β-neutralizing monoclonal antibodies (lead program FL‑101) for cancer and other chronic inflammatory diseases.

Founded 2017

New York, United States

1-10

Private

flame.bio

Highlights

Focus Areas

Biotechnology

Health Care

Medical

Recent Investors

A

Financials

$100M

Total Raised

1

Funding round

10

Investors

Team

Upgrade to view the team

See the team members at Flame Biosciences.